Evaluation of Liver Maximum Capacity Measurements to Monitor Hepatocellular Function During Extended Normothermic Machine Perfusion
Authors:
- 17 November 2025
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 110 (2) , e395-e404
Abstract
Background.: Although lactate clearance provides important information regarding hepatocellular function during normothermic machine perfusion (NMP), the information inferred is adequate to exclude nonfunctioning grafts but is limited in evaluating comprehensive hepatocyte function. Liver maximum capacity (LiMAx), using C 13 -methacetin, has been adopted to assist in the functional assessment of the liver before major oncological resection. We evaluated the combined use of lactate clearance and LiMAx measurement to monitor liver function during extended-duration NMP. Methods.: Seven discarded donor livers underwent extended NMP for 87–184 h using a blood-based perfusate and a modified Liver Assist device incorporating hemofiltration. Hepatocellular function was assessed every 6 h using LiMAx: a fixed bolus of C 13 -methacetin was administered and the delta over baseline was measured. Lactate clearance capacity was tested every 24 h by administering 50% sodium lactate to achieve perfusate concentrations of 10–15 mmol/L. Results.: Initial lactate clearance to <2.5 mmol/L was achieved within 1.75–7.75 h post-NMP initiation. The median LiMAx value was 829 (range, 325–3130) µg/kg/h. Livers with efficient lactate clearance (<4 h) displayed stable LiMAx profiles with consistently low, flat delta over baseline curves, maintaining similar amplitude for 80 h of perfusion, indicative of preserved hepatocyte function. Conversely, livers with progressive reductions in LiMAx amplitude and curve flattening were associated with deteriorating function and eventual graft failure. Conclusions.: LiMAx enables real-time, longitudinal monitoring of hepatocyte metabolic activity during extended NMP. When combined with lactate clearance, it could offer a more comprehensive assessment of graft viability. Incorporating LiMAx into viability criteria could refine current decision-making frameworks for liver transplantation, particularly in marginal grafts.Keywords
This publication has 31 references indexed in Scilit:
- Viability assessment and transplantation of extended criteria donor liver grafts using normothermic machine perfusionSurgery, 2024
- Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 HoursLiver Transplantation, 2021
- Transplantation of discarded livers following viability testing with normothermic machine perfusionNature Communications, 2020
- An integrated perfusion machine preserves injured human livers for 1 weekNature Biotechnology, 2020
- Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver CirrhosisDigestive Diseases and Sciences, 2018
- Development of Clinical Criteria for Functional Assessment to Predict Primary Nonfunction of High‐Risk Livers Using Normothermic Machine PerfusionLiver Transplantation, 2018
- A randomized trial of normothermic preservation in liver transplantationNature, 2018
- From “Gut Feeling” to Objectivity: Machine Preservation of the Liver as a Tool to Assess Organ ViabilityCurrent Transplantation Reports, 2018
- Metabolic zonation of the liver: The oxygen gradient revisitedRedox Biology, 2017
- First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusionLiver Transplantation, 2015